Physician profile
Timothy Devraj
NPI 1760415632
$4,253.11
in general payments reported to CMS, 2019-2025
37 companies · $750 in 2025
The $750 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,057 · 2020: $454 · 2021: $419 · 2022: $373 · 2023: $661 · 2024: $539 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,949.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,448.11 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Aequalis Perform |
| Depuy Synthes Sales INC. | $306.11 | 2019-2025 | Na |
| Ferring Pharmaceuticals INC. | $139.51 | 2019-2025 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $126.10 | 2023 | |
| Novo Nordisk INC | $95.14 | 2021-2023 | Ozempic, Rybelsus |
| Pacira Therapeutics, INC. | $92.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.86 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $84.81 | 2021-2022 | |
| Abbvie INC. | $81.69 | 2019-2024 | Ubrelvy |
| Kowa Pharmaceuticals America, INC. | $64.72 | 2023 | Seglentis, Livalo |
| Horizon Therapeutics Plc | $58.45 | 2020-2022 | |
| Abbott Laboratories | $57.64 | 2022-2023 | Freestyle Libre |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.76 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $52.98 | 2023-2025 | Exparel, Iovera, Zilretta |
| Avanos Medical | $51.97 | 2019-2025 | On-Q Pump and Accessories |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $45.17 | 2024-2025 | |
| Alon Medical Technology | $39.57 | 2024 | |
| Radius Health, INC. | $32.41 | 2021 | |
| Boston Scientific Corporation | $29.81 | 2021 | |
| Organogenesis INC. | $29.50 | 2025 | Puraply Wound Matrix |
| Alnylam Pharmaceuticals INC. | $20.64 | 2020 | |
| Kyowa Kirin, INC. | $20.32 | 2024 | Crysvita |
| Heron Therapeutics, INC. | $19.23 | 2025 | Aponvie |
| Innovation Technologies INC | $18.50 | 2024 | Irrisept |
| Bayer Healthcare Pharmaceuticals INC. | $18.24 | 2024 | |
| Endo Pharmaceuticals INC. | $17.78 | 2019 | |
| Amgen INC. | $17.00 | 2019 | |
| Sonex Health, INC. | $17.00 | 2024 | Sx-One Microknife |
| Merck Sharp & Dohme LLC | $16.42 | 2022 | |
| Dexcom, INC. | $16.38 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $15.75 | 2025 | |
| Amarin Pharma, INC. | $15.51 | 2019 | |
| Insulet Corporation | $15.42 | 2023 | Omnipod |
| Vericel Corporation | $14.20 | 2020 | |
| Exact Sciences Corporation | $14.12 | 2023 | Cologuard Collection Kit |
| Kerecis Limited | $9.97 | 2020 | |
| Spr Therapeutics, INC | $4.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Devraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.